Date: 2025/04/02 - 23:32
The FDA's new rule restricting the sale of compounded semaglutide could make it more difficult for some people to obtain affordable weight loss medications. Here, two people who've relied on compounded GLP-1 drugs share their stories.
Date: 2025/04/02 - 23:00
The FDA's new rule restricting the sale of compounded semaglutide could make it more difficult for some people to obtain affordable weight loss medications. Here, two people who've relied on compounded GLP-1 drugs share their stories.
Date: 2025/03/28 - 17:00
Following specific dietary patterns, especially one that scores high on the Alternative Healthy Eating Index, may help a person age healthy with no chronic diseases or cognitive issues at age 70, a new study suggests.
Date: 2025/03/24 - 23:00
A new study suggests that certain cardiovascular risk factors could significantly impact females more than males. Taking biological sex into account during routine screenings could provide a clearer assessment of cardiovascular risk, the researchers say.
Date: 2025/03/21 - 20:31
Higher and more intense levels of physical activity may not benefit life span as much as previously thought, a new study in twins finds, highlighting multiple factors that play a role in longevity.
Date: 2025/03/20 - 00:00
The FDA ordered compounding pharmacies to stop making copycat versions of weight loss drugs like Ozempic and Zepbound now that the GLP-1 drug shortage has ended. People who rely on compounded GLP-1s say they may not be able to afford brand-name versions, which are often not covered by insurance.